Key result
Serum LOX-1 shows diagnostic utility for HFrEF alongside NT-proBNP.
Answers are grounded in this paper and cite their sources.
Evaluates the relationship between serum LOX-1 levels and heart failure, suggesting potential diagnostic utility.
Objectives Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) appears to be involved in atherosclerotic plaque vulnerability and rupture. In this study, we aimed to evaluate the utility of serum LOX-1 levels in the diagnosis and assessment of left ventricular systolic HF and LOX-1's relationship with serum pro-brain natriuretic peptide (NT-proBNP).
No takes yet. Share an insight, caveat, or question.
Sarandöl et al. (2016) studied this question. Serum lectin-like oxidized LDL receptor-1 (LOX-1) levels were evaluated for their utility in diagnosing left ventricular systolic heart failure and their relationship with NT-proBNP.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: